Ozempic under the microscope: new study tracks Real-World safety in korean diabetes patients
NCT ID NCT05689372
First seen Jan 05, 2026 · Last updated Jun 13, 2026 · Updated 25 times
Summary
This study follows 600 adults with type 2 diabetes who are already starting Ozempic as part of their normal care. Researchers will track side effects and blood sugar control over about 26 weeks. The goal is to confirm the drug works safely in real-world settings, not just in controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wonkwang University Hospital
Jeonlabuk-do, 54538, South Korea
Conditions
Explore the condition pages connected to this study.